Global Transdermal Scopolamine Market : Segmental Highlights and Table of Content (2016 - 2024)
The opportunity in the global transdermal scopolamine market was pegged at US$330.0 mn in 2015 and is poised to reach a valuation of US$585.3 mn by the end of 2024, progressing at a healthy CAGR of 6.70% between 2016 and 2024.
View full press release